Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
"The future of Elixinol is so exciting for me. We have finally reached a scale and maturity where we have farming, production, formulas, trusted branding, great relationships, a superb management team, excellent systems and a plethora of opportunities at our doorstep we are capable of meeting through our quality control systems and growth capacity. For now, it is all about the execution of our vision: to provide the best, highest quality hemp products to the market, via mainstream channels, through our trusted brand, based on science and technology, globally. Elixinol is and will continue to be a leading global hemp CBD brand."
insert-text-here
Mitch McConnell Tells FDA To Clear A Path For CBD Products Though Spending Bill Directive: insert-text-here
Response to Greg Miller:
1 - ELLXF doesn't sell high dose or low dose CBD. They sell CBD which you then dose yourself as high or low as you want. So this comment is invalid.
2 - It is true they don't sell isolates currently. Thought I think they will be bring out Broad Spectrum CBD down the road (i.e. no THC) along with their Full Spectrum CBD. I think ELLXF thinks that Full Spectrum is best due to the entourage effect. However, maybe the Broad Spectrum is good if you are concerned about drug tests etc. I would only use Full Spectrum. So this point doesn't concern me.
3 - He says they avoid some of the hottest products in the market like skin creams. A simple search of Elixinol's website would show CBD based topicals and HEMP line Sativa. So this is just false.
4 - Price: you pay for what you get. With Elixinol you get the highest quality throughout the process. So if you want cheaper, and most likely shittier products - go for it. However, I think alot of those products may soon face a regulatory backlash that ELLXF will avoid. Whether it is do to with farming practices (think Hemp Authority), or testing of how much CBD is actually in a product, or heavy metals etc - Elixinol will distinguish itself by the lack of regulatory interference. That's part of Brand Building.
5 - He makes a big assumption that the FDA will full y approve CDB in Food + Beverages. I think these are the areas with the most risk - due to drugs being in the food supply.
6 - Branding. I do agree that Elixinol's branding could connect more emotionally. I think this an area that they maybe working on. It cant be simply a science based lift. Once people accept CBD - emotionality is the connector.
7 - I also disagree with his negativity about international markets. I think this is good risk management (when faced with the Feds) and will pay-off down the line.
8 - Pet Releaf - it's good to have more revenue - provides liquidity going forward. Which I think they will also get with the increased production capacity in Colorado + the raw hemp they have secured + the inventory build-up. Now they just need to ship and market it. That will provide the revenue to continue expansion.
Who? Cannabis Investor's?
Do they have a website?
Today the mm’s covered a lot of short shares against their large short positions, thanks to the baseless article that they planted through their buddy-author. Soon they will stop algo-ing the stock down.
Thanks, Ania77. Figured that was the case and added even before I knew why the free fall. Nice to see it confirmed.
Newsletter sell? Ha! simple logic, just do the opposite. Easiest trade in the book, I think this may be bottom finally? Third times the charm
Most likely a paid hit piece written by a puppet analyst.
I too am holding. I was worried it was something important you know....like facts :)
Guy probably shorted to make a quick buck.
Absolutely BS move and reasoning behind it imo Newsletter guy also said that he doesn't like that company is not interested in hemp/CBD cream line which are hot products.. umm excuse me? doesn't he know that actually ELIXINOL has probably the biggest skin line 'Sativa' made with organic hemp with 8 SKUs? Did he miss that ?
Also Elixinol have top people working for company that are true pioneers of hemp industry when it comes to farming and regulations.
I'm holding all my shares.
incredible
$50m in cash / worldwide exposure / many catalyst on the horizon and a some guy writes an opinion says he doesn't like elixinol tanks the stock
This emotional market place is wearing me out.
Newsletter cannabis investors just sent email to sell Elixinol and move money somewhere else.. the reason behind it is solely that the guy doesn't like their approach.. that they are too 'scientific'.. he doesn't like that company believes that higher strength and full spectrum is better than pure CBD of lower doses = the guy from Cannabis Investor's has no clue..
That to be said we may see some bargain prices if someone is interested to add and has patience to hold
Glta
Yeah _ I have my eye on this. I am excited beyond CBD for ELLXF. The medical weed licence in Oz could set them up to be the Canopy Growth etc of that country. But this - bioplastics - is HUGE and the world needs this even more than CBD or weed. I love this.
Picked up 1000 shares @$1.50 Monday and Tuesday.
First time I got in here I believe I paid $2.60...and I thought that was decent.
Partial fills over and over on low volume but glad I got at least a small position at such a steal.
Check out this January post, Pan O War.
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=145827717&txt2find=plastics
Apparently he wasn't kidding. https://hempplastic.com/about-us/
"We’re also excited to increase sustainability by planning to use the waste from the hemp plant (after extraction to create our CBD products), to form bio-plastics which I hope will make a difference to our oceans." - Paul Benhaim.
Probably newsletter again but if you haven’t noticed the whole POT sector is going and of course the profitable cbd companies will catch some off of it. But besides that ELLXF is sitting back where it started ... buy it and quit questioning things. Lol
For the same reason it will probably shoot back down tomorrow. NO Reason.
There is really not much needed to move ELLXF 10% up.. little bit of volume and goes up. It's very thin.
Wondering that myself
Things I am looking forward to w/ELLXF:
- FDA Clarity
- European Revenue hitting the books
- Hemp burgers in Oz supermarkets
- Cost efficiencies from Colorado Production Facility + doubling capacity
- Nunyara Cultivation License
- Constructive discussions w/large retailers as well as large food, drug and mass retail segment
- New Elixinol branded products launching H2 2019
- Microencapsulation
- New distribution channels being discussed, predominately the UK
- New Hemp foods
They love it, they hate it.. notice the small daily range here. What’s she doin... previous price areas are potential buy zones but I started a bit early.
What's wrong here? This stock isn't getting any love. Actually not even getting any like. Looks like mostly hate of late.
"2 falling ASX cannabis stocks to watch closely"
https://www.fool.com.au/2019/09/02/2-falling-asx-cannabis-stocks-to-watch-closely/
From Forbes:
Pet Releaf’s lineup for dog CBD is absolutely one of the most complete on this list. It’s clear they’ve not only have thought through all the different reasons why dogs would take CBD but the specific methods that’ll make it easier for them to ingest it. A wise choice overall, and one with nothing but upside.
https://www.forbes.com/sites/joresablount/2019/08/30/cbd-for-dogs-the-best-products-on-the-market-based-on-quality/#4665b57760be
I agree in general. It’s a land grab situation.
It’s never 100% on anything but I’d put my money with someone who’s willing to invest in there company for the future than not.
“The distribution agreement with 25th Group allows Elixinol to establish a dominant position across central Europe and launch Elixinol branded
products throughout retail channels in Benelux and Switzerland.”
Elixinol signs exclusive distribution agreement for Belgium and
Luxembourg
insert-text-here
Well, I hope you are correct, of course.
At this point, it’s all about brand. About distinguishing yourself from others. As they say, you never get a second chance to make a first impression.
As many consumers are just getting acquainted with cbd, now is the time to market heavily. Agree with the priority.
~yanqui
Well, it’s not always wise. It’s wise if it works. Having $18m in revenue and spending $3.7m on marketing just seems like a lot to me. So I hope the marketing works, as I said.
Investing into ones company is always wise bigger profits later GLTA
They are sure spending a lot on marketing, 21% of revenue. Hope that pays off.
US strategy shift causes growth pains for Elixinol
insert-text-here
Cannabis company Elixinol Global posts 19% increase in half year revenue to $18.3 million - Motley Fool:
insert-text-here
Followers
|
26
|
Posters
|
|
Posts (Today)
|
0
|
Posts (Total)
|
1174
|
Created
|
09/18/18
|
Type
|
Free
|
Moderators |
50 Pitt Street,
Level 6
Sydney, NSW 2000
Australia
Volume | |
Day Range: | |
Bid Price | |
Ask Price | |
Last Trade Time: |